Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.

Author: MelanderB, RosenhallL, SandströmT, WallinA, WåhlanderL

Paper Details 
Original Abstract of the Article :
Sixteen patients with stable chronic asthma participated in a double blind crossover study comparing the new inhaled long acting beta 2 agonist formoterol with salbutamol. Inhaled (n = 15) and oral steroid (n = 1) treatment were maintained at the same daily dose throughout the study. For four weeks ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/thx.45.4.259

データ提供:米国国立医学図書館(NLM)

Formoterol: A Long-Acting Beta 2 Agonist for Asthma Control

The world of asthma treatment is vast and complex, like a sprawling desert with many hidden oases. This research delves into the effectiveness of a new long-acting beta 2 agonist, formoterol, for managing asthma symptoms. The study, a double-blind crossover design, compared formoterol with salbutamol in 16 patients with stable chronic asthma. The results revealed that formoterol, when administered twice daily, led to fewer additional puffs of beta 2 agonist, improved symptom scores, less disturbed sleep, more days without additional aerosol, and higher peak expiratory flow (PEF) both morning and evening compared to salbutamol. This suggests that formoterol provides long-lasting bronchodilatation and effectively controls asthma symptoms with regular twice-daily administration.

Formoterol: A Promising Option for Asthma Management

The study found that formoterol demonstrated superior efficacy in controlling asthma symptoms compared to salbutamol. This is especially important for patients with chronic asthma, who often experience fluctuating symptoms and require frequent medication adjustments. The results highlight the potential of formoterol as a valuable tool for managing asthma and improving patients' quality of life.

Formoterol: A Potential Oasis for Asthma Sufferers

These findings suggest that formoterol could be a welcome oasis for individuals living with chronic asthma. Its ability to provide long-lasting relief and improve symptom control could lead to better sleep, fewer disruptions to daily activities, and a higher quality of life. However, it is crucial to consult with a medical professional to determine if formoterol is the right treatment option for you, as individual responses to medications can vary.

Dr. Camel's Conclusion

Formoterol emerged as a promising long-acting beta 2 agonist for asthma control in this study. Its effectiveness in reducing symptom severity and improving overall well-being suggests that it could offer significant benefits to individuals seeking to manage their asthma symptoms. However, as with any medication, individual responses can vary, so consulting a doctor is essential for tailored treatment plans.

Date :
  1. Date Completed 1990-07-24
  2. Date Revised 2019-05-03
Further Info :

Pubmed ID

1972599

DOI: Digital Object Identifier

10.1136/thx.45.4.259

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.